COVID-19. U07.1: COVID-19, Virus identified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age between 18 to 85 years Ability to communicate and answer questions Consent to participate in the study and sign the informed consent form The patient is alert The patient should not be intubated The percentage of oxygen saturation of the patient's blood is below 93%
Exclusion criteria
Exclusion criteria: Patient dissatisfaction with continuing the study Adverse changes in vital signs (blood oxygen saturation level, heart rate, respiration and blood pressure)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dyspnea. Timepoint: Patients' rate of Dyspnea at the beginning of the study (before the intervention) and immediately after the start of the study. Method of measurement: Borg's Category Ratio Scale ( CR10 ) and Visual Analog Scales ( VAS).;Cough. Timepoint: Number of patients coughing at the beginning of the study (before the intervention) and immediately after the start of the study. Method of measurement: Record the number of coughs using a checklist prepared by the researcher.;Breathing. Timepoint: The number of patients breathing at the beginning of the study (before the intervention) and immediately after the start of the study. Method of measurement: Record the number of breathing using a checklist prepared by the researcher.;Blood oxygen saturation level. Timepoint: Percentage of blood oxygen saturation of patients at the beginning of the study (before the intervention) and immediately after the start of the study. Method of measurement: Pulse oximeter connected to the monitor model LK88. | — |
Countries
Iran (Islamic Republic of)
Contacts
Yasouj University of Medical Sciences